Streetbeat News

ECOR

electroCore, Inc.

https://www.electrocore.com

Industry

Medical - Devices

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Open

8.52

Mkt cap

60M

Volume

241K

High

8.67

P/E Ratio

-5.27

52-wk high

19.49

Low

7.99

Div yield

N/A

52-wk low

5.32

electroCore reported record net sales of $25.2 million for 2024, a 57% increase from 2023. This growth was driven by an 85% increase in Rx gammaCore sales to the US Department of Veteran Affairs and Department of Defense, and a 174% rise in Truvaga sales.

Portfolio Pulse from

March 12, 2025 | 8:30 pm

electroCore, Inc. (Nasdaq: ECOR) will release its Q4 and full-year 2024 financial results on March 12, 2025, after market close.

Portfolio Pulse from

March 06, 2025 | 1:15 pm

Ecora Resources has announced a $50 million deal to acquire an interest in a copper revenue stream from Moxico Resources' Mimbula copper mine in Zambia. This move aligns with Ecora's strategy to focus on royalties and streams, promising immediate earnings and cash flow growth.

Portfolio Pulse from

March 01, 2025 | 10:15 am

electroCore, Inc. has entered into an agreement with Spark Biomedical to distribute the FDA-cleared Sparrow Ascent device for opioid withdrawal in certain VA facilities.

Portfolio Pulse from

February 27, 2025 | 1:15 pm

Ecora Resources has acquired a copper stream from Moxico Resources' Mimbula copper mine in Zambia for $50 million, covering the mine's 11-year Life of Mine with potential for extension.

Portfolio Pulse from

February 27, 2025 | 8:00 am

electroCore (ECOR) has been identified as a strong choice for trend investors due to its recent price strength, suggesting potential for profit as the stock is currently on the move.

Portfolio Pulse from

February 12, 2025 | 3:00 pm

electroCore, Inc. (Nasdaq: ECOR) will participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 11-12, 2025, in Snowbird, Utah.

Portfolio Pulse from

February 04, 2025 | 1:15 pm

Ecora Resources PLC reported a portfolio income of US$63 million for 2024, slightly above market estimates. The company has started receiving a contingent consideration from Narrabri, with US$3 million already received in January.

Portfolio Pulse from

January 29, 2025 | 3:30 pm

Ecora Resources reported a 29% increase in income for the fourth quarter, driven by record production volumes at Voisey's Bay and Mantos Blancos. This highlights the company's strong performance in copper and cobalt production.

Portfolio Pulse from

January 29, 2025 | 7:45 am

electroCore (ECOR) is highlighted as a stock with strong recent price momentum, making it a potential choice for investors looking for stocks with an uptrend.

Portfolio Pulse from

January 27, 2025 | 3:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.